🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximal tolerated dose (MTD) ...
Status
Completed
Location
University of Alabama
Start Date
2014-02-28
Trial ID
NCT01983501
Treatments Being Tested
Women or men with HER2-positive, metastatic breast cancer, who have progres...
Status
Terminated
Location
Coffs Harbour Health Campus
Start Date
2023-03-07
Trial ID
NCT04789096
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of ribociclib...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2022-04-07
Trial ID
NCT05319873
A phase 2 non-randomized study to assess the safety and efficacy of the com...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2019-02-20
Trial ID
NCT03501979
Treatments Being Tested
The H3RAKLES trial would allow patients with a progressive metastatic breas...
Status
Recruiting
Location
Polyclinique Bordeaux Nord Aquitaine
Start Date
2026-01-31
Trial ID
NCT07193394
Treatments Being Tested
The JAZMINE study is a multicenter, open-label, non-comparative, phase Ib/I...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07494448
Treatments Being Tested
This study is being done to find out if tucatinib with other cancer drugs w...
Status
Recruiting
Location
Palo Verde Hematology Oncology
Start Date
2022-10-24
Trial ID
NCT05253651
Treatments Being Tested
This study is being done to see if tucatinib with ado-trastuzumab emtansine...
Status
Active Not Recruiting
Location
University of South Alabama Health Children's and Women's Hospital
Start Date
2019-10-02
Trial ID
NCT03975647
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-12-28
Trial ID
NCT04538742
Treatments Being Tested
This study is being done to compare the pharmacokinetics (PK) and safety/to...
Status
Completed
Location
PAREXEL International, Early Phase Clinical Unit - Los Angeles
Start Date
2019-05-08
Trial ID
NCT03914755
Treatments Being Tested